Literature DB >> 10426388

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.

H Eldar-Finkelman1, S A Schreyer, M M Shinohara, R C LeBoeuf, E G Krebs.   

Abstract

Although the precise mechanisms contributing to insulin resistance and type 2 diabetes are unknown, it is believed that defects in downstream components of the insulin signaling pathway may be involved. In this work, we hypothesize that a serine/threonine kinase, glycogen synthase kinase-3 (GSK-3), may be pertinent in this regard. To test this hypothesis, we examined GSK-3 activity in two inbred mouse strains known to be susceptible (C57BL/6J) or resistant (A/J) to diet-induced obesity and diabetes. Examination of GSK-3 in fat, liver, and muscle tissues of C57BL/6J mice revealed that GSK-3 activity increased twofold in the epididymal fat tissue and remained unchanged in muscle and liver of mice fed a high-fat diet, compared with their low-fat diet-fed counterparts. In contrast, GSK-3 activity did not change in the epididymal fat tissue of A/J mice, regardless of the type of diet they were fed. In addition, both basal and diet-induced GSK-3 activity was higher (2.3- and 3.2-fold, respectively) in the adipose tissue of C57BL/6J mice compared with that in A/J mice. Taken together, our studies suggest an unsuspected link between increased GSK-3 activity and development of insulin resistance and type 2 diabetes in fat tissue of C57BL/6J mice, and implicate GSK-3 as a potential factor contributing to susceptibility of C57BL/6J mice to diet-induced diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426388     DOI: 10.2337/diabetes.48.8.1662

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  81 in total

1.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

Review 2.  Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.

Authors:  Richard S Jope; Christopher J Yuskaitis; Eléonore Beurel
Journal:  Neurochem Res       Date:  2006-08-30       Impact factor: 3.996

Review 3.  Circadian rhythms and the regulation of metabolic tissue function and energy homeostasis.

Authors:  Sanjin Zvonic; Z Elizabeth Floyd; Randall L Mynatt; Jeffrey M Gimble
Journal:  Obesity (Silver Spring)       Date:  2007-03       Impact factor: 5.002

4.  Phosphorylation of glycogen synthase kinase-3β in metabolically abnormal obesity affects immune stimulation-induced cytokine production.

Authors:  C-L Yen; W-C Chao; C-H Wu; Y-F Huang; C-S Chang; Y-S Tsai; C-F Lin; C-C Shieh
Journal:  Int J Obes (Lond)       Date:  2014-05-23       Impact factor: 5.095

5.  Synthesis and Initial in Vivo Studies with [(11)C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3.

Authors:  Lei Li; Xia Shao; Erin L Cole; Stephan A Ohnmacht; Valentina Ferrari; Young T Hong; David J Williamson; Tim D Fryer; Carole A Quesada; Phillip Sherman; Patrick J Riss; Peter J H Scott; Franklin I Aigbirhio
Journal:  ACS Med Chem Lett       Date:  2015-03-10       Impact factor: 4.345

6.  Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.

Authors:  Erik J Henriksen; Mary K Teachey
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

Review 7.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

8.  Nutritional programming in the rat is linked to long-lasting changes in nutrient sensing and energy homeostasis in the hypothalamus.

Authors:  Ricardo Orozco-Solís; Rhowena J B Matos; Omar Guzmán-Quevedo; Sandra Lopes de Souza; Audrey Bihouée; Rémi Houlgatte; Raul Manhães de Castro; Francisco Bolaños-Jiménez
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

9.  Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.

Authors:  Massimo Collino; Manuela Aragno; Sara Castiglia; Chiara Tomasinelli; Christoph Thiemermann; Giuseppe Boccuzzi; Roberto Fantozzi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

10.  Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.

Authors:  Takayuki Miki; Tetsuji Miura; Hiroyuki Hotta; Masaya Tanno; Toshiyuki Yano; Takahiro Sato; Yoshiaki Terashima; Akifumi Takada; Satoko Ishikawa; Kazuaki Shimamoto
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.